Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

Cello restructures its health brand

Will integrate MSI, Insight, MedErgy, Cello Business Sciences and Mash Health

- PMLiVE

AZ gets green light for Bydureon pen in US

FDA approval comes after year-long delay

Roche - Basel

Roche drug fails in lung cancer trial

Damages prospects for onartuzumab

- PMLiVE

PhRMA appoints senior government affairs position

Charles Clapton has senior experience on Capitol Hill

- PMLiVE

Use data responsibly

It’s imperative that opening up clinical trial data doesn’t compromise patient safety

- PMLiVE

Novartis to close UK R&D site

Research operations at Horsham expected to end in June

- PMLiVE

NICE set to reject Lilly’s Alimta for new use in lung cancer

Drug deemed not cost-effective use of NHS resources in new indication

- PMLiVE

Bayer raises sales predictions for new pharma products

Expects Xarelto, Eylea, Stivarga, Xofigo and Adepas to make €7.5bn at peak

- PMLiVE

Gliptins don’t cause pancreatic cancer say FDA and EMA

Regulators back safety of diabetes medicine class

- PMLiVE

Pharma companies back Rare Disease Day

Genzyme, Shire and more hold global campaigns today

- PMLiVE

Back to school: client service 101

Simple advice to renew your business model for client service

Bayer symbol

Bayer buys Chinese consumer care company

Acquires Dihon Pharmaceutical as Algeta takeover closes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links